268 related articles for article (PubMed ID: 17014845)
1. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
3. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
[TBL] [Abstract][Full Text] [Related]
4. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 controls BRCA1 gene expression and cellular localization in human breast cancer cells.
Glait C; Ravid D; Lee SW; Liscovitch M; Werner H
FEBS Lett; 2006 Oct; 580(22):5268-74. PubMed ID: 16979166
[TBL] [Abstract][Full Text] [Related]
6. Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene.
Abramovitch S; Werner H
Horm Metab Res; 2003; 35(11-12):758-62. PubMed ID: 14710355
[TBL] [Abstract][Full Text] [Related]
7. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
[TBL] [Abstract][Full Text] [Related]
8. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
Werner H; Maor S
Trends Endocrinol Metab; 2006 Aug; 17(6):236-42. PubMed ID: 16815029
[TBL] [Abstract][Full Text] [Related]
9. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations.
Maor S; Yosepovich A; Papa MZ; Yarden RI; Mayer D; Friedman E; Werner H
Cancer Lett; 2007 Nov; 257(2):236-43. PubMed ID: 17766039
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
Zhang H; Pelzer AM; Kiang DT; Yee D
Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1.
Maor S; Papa MZ; Yarden RI; Friedman E; Lerenthal Y; Lee SW; Mayer D; Werner H
Horm Metab Res; 2007 Mar; 39(3):179-85. PubMed ID: 17373631
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1.
Maor SB; Abramovitch S; Erdos MR; Brody LC; Werner H
Mol Genet Metab; 2000 Feb; 69(2):130-6. PubMed ID: 10720440
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.
Sarfstein R; Maor S; Reizner N; Abramovitch S; Werner H
Mol Cell Endocrinol; 2006 Jun; 252(1-2):241-6. PubMed ID: 16647191
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
[TBL] [Abstract][Full Text] [Related]
15. p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy.
Attias-Geva Z; Bentov I; Kidron D; Amichay K; Sarfstein R; Fishman A; Bruchim I; Werner H
Eur J Cancer; 2012 Jul; 48(10):1570-80. PubMed ID: 22033326
[TBL] [Abstract][Full Text] [Related]
16. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
[TBL] [Abstract][Full Text] [Related]
17. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
18. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
19. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
Sarfstein R; Werner H
J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.
Rubinstein M; Idelman G; Plymate SR; Narla G; Friedman SL; Werner H
Endocrinology; 2004 Aug; 145(8):3769-77. PubMed ID: 15131018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]